Annual Review of Biochemistry, volume 82, issue 1, pages 775-797

Nanobodies: Natural Single-Domain Antibodies

Publication typeJournal Article
Publication date2013-06-02
Q1
Q1
SJR9.745
CiteScore33.9
Impact factor12.1
ISSN00664154, 15454509
Biochemistry
Abstract

Sera of camelids contain both conventional heterotetrameric antibodies and unique functional heavy (H)-chain antibodies (HCAbs). The H chain of these homodimeric antibodies consists of one antigen-binding domain, the VHH, and two constant domains. HCAbs fail to incorporate light (L) chains owing to the deletion of the first constant domain and a reshaped surface at the VHH side, which normally associates with L chains in conventional antibodies. The genetic elements composing HCAbs have been identified, but the in vivo generation of these antibodies from their dedicated genes into antigen-specific and affinity-matured bona fide antibodies remains largely underinvestigated. However, the facile identification of antigen-specific VHHs and their beneficial biochemical and economic properties (size, affinity, specificity, stability, production cost) supported by multiple crystal structures have encouraged antibody engineering of these single-domain antibodies for use as a research tool and in biotechnology and medicine.

Found 
Found 

Top-30

Journals

10
20
30
40
50
60
70
Frontiers in Immunology
63 publications, 3.73%
International Journal of Molecular Sciences
40 publications, 2.37%
Scientific Reports
37 publications, 2.19%
PLoS ONE
28 publications, 1.66%
Journal of Biological Chemistry
24 publications, 1.42%
Methods in Molecular Biology
24 publications, 1.42%
Analytical Chemistry
23 publications, 1.36%
Nature Communications
22 publications, 1.3%
Antibodies
20 publications, 1.18%
Biomolecules
16 publications, 0.95%
Proceedings of the National Academy of Sciences of the United States of America
16 publications, 0.95%
mAbs
15 publications, 0.89%
International Journal of Biological Macromolecules
15 publications, 0.89%
Protein Science
14 publications, 0.83%
eLife
14 publications, 0.83%
Toxins
13 publications, 0.77%
Journal of Agricultural and Food Chemistry
12 publications, 0.71%
Biochemical and Biophysical Research Communications
11 publications, 0.65%
Molecular Pharmaceutics
10 publications, 0.59%
Frontiers in Microbiology
9 publications, 0.53%
Sensors and Actuators, B: Chemical
9 publications, 0.53%
Analytica Chimica Acta
9 publications, 0.53%
Journal of Controlled Release
9 publications, 0.53%
Protein Expression and Purification
9 publications, 0.53%
ChemBioChem
9 publications, 0.53%
Journal of Immunology
8 publications, 0.47%
Viruses
8 publications, 0.47%
Molecules
8 publications, 0.47%
Cancers
8 publications, 0.47%
10
20
30
40
50
60
70

Publishers

50
100
150
200
250
300
350
400
Elsevier
368 publications, 21.78%
Springer Nature
272 publications, 16.09%
MDPI
174 publications, 10.3%
Wiley
144 publications, 8.52%
Cold Spring Harbor Laboratory
126 publications, 7.46%
Frontiers Media S.A.
111 publications, 6.57%
American Chemical Society (ACS)
102 publications, 6.04%
Taylor & Francis
62 publications, 3.67%
Public Library of Science (PLoS)
36 publications, 2.13%
Royal Society of Chemistry (RSC)
26 publications, 1.54%
American Society for Biochemistry and Molecular Biology
22 publications, 1.3%
Oxford University Press
21 publications, 1.24%
American Society for Microbiology
16 publications, 0.95%
Proceedings of the National Academy of Sciences (PNAS)
16 publications, 0.95%
eLife Sciences Publications
14 publications, 0.83%
Annual Reviews
12 publications, 0.71%
The American Association of Immunologists
8 publications, 0.47%
American Association for the Advancement of Science (AAAS)
7 publications, 0.41%
SAGE
7 publications, 0.41%
Pleiades Publishing
7 publications, 0.41%
Bentham Science Publishers Ltd.
6 publications, 0.36%
Portland Press
6 publications, 0.36%
Walter de Gruyter
6 publications, 0.36%
American Association for Cancer Research (AACR)
6 publications, 0.36%
American Society for Pharmacology and Experimental Therapeutics
5 publications, 0.3%
Ovid Technologies (Wolters Kluwer Health)
5 publications, 0.3%
Federation of American Societies for Experimental Biology (FASEB)
5 publications, 0.3%
The Company of Biologists
4 publications, 0.24%
International Union of Crystallography (IUCr)
4 publications, 0.24%
50
100
150
200
250
300
350
400
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Muyldermans S. Nanobodies: Natural Single-Domain Antibodies // Annual Review of Biochemistry. 2013. Vol. 82. No. 1. pp. 775-797.
GOST all authors (up to 50) Copy
Muyldermans S. Nanobodies: Natural Single-Domain Antibodies // Annual Review of Biochemistry. 2013. Vol. 82. No. 1. pp. 775-797.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1146/annurev-biochem-063011-092449
UR - https://doi.org/10.1146/annurev-biochem-063011-092449
TI - Nanobodies: Natural Single-Domain Antibodies
T2 - Annual Review of Biochemistry
AU - Muyldermans, Serge
PY - 2013
DA - 2013/06/02
PB - Annual Reviews
SP - 775-797
IS - 1
VL - 82
SN - 0066-4154
SN - 1545-4509
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2013_Muyldermans,
author = {Serge Muyldermans},
title = {Nanobodies: Natural Single-Domain Antibodies},
journal = {Annual Review of Biochemistry},
year = {2013},
volume = {82},
publisher = {Annual Reviews},
month = {jun},
url = {https://doi.org/10.1146/annurev-biochem-063011-092449},
number = {1},
pages = {775--797},
doi = {10.1146/annurev-biochem-063011-092449}
}
MLA
Cite this
MLA Copy
Muyldermans, Serge. “Nanobodies: Natural Single-Domain Antibodies.” Annual Review of Biochemistry, vol. 82, no. 1, Jun. 2013, pp. 775-797. https://doi.org/10.1146/annurev-biochem-063011-092449.
Found error?